ATC code D11

Anatomical Therapeutic Chemical (ATC) classification – Dermatologicals (Other dermatologicals)


Overview

ATC code D11 designates the subgroup “Other dermatologicals” within the World Health Organization’s Anatomical Therapeutic Chemical (ATC) Classification System. The ATC system groups drugs and medical products according to the organ or system on which they act and their therapeutic, pharmacological, and chemical properties.

The D‑series covers Dermatologicals, i.e., substances intended for topical, local, or systemic use on the skin. Within this series, the D11 subgroup collects dermatological preparations that do not belong to the more specific therapeutic categories (e.g., antifungals, corticosteroids, anti‑acne agents).


Position in the ATC Hierarchy

Level Code Description
1 – Anatomical main group D Dermatologicals
2 – Therapeutic subgroup D11 Other dermatologicals
3 – Pharmacological subgroup varies (e.g., D11AA, D11AB, …)
4 – Chemical subgroup varies
5 – Chemical substance specific active ingredient

Note: The third‑level codes (e.g., D11AA, D11AB, D11AC, etc.) further split the “Other dermatologicals” category into pharmacologically distinct groups such as antibiotics, antiseptics, keratolytics, and other agents.


Typical Pharmacological Sub‑groups (selected)

ATC code Pharmacological theme Representative agents
D11AA Antibacterial preparations for skin Mupirocin, fusidic acid
D11AB Antiseptic preparations for skin Chlorhexidine, povidone‑iodine
D11AC Keratolytic agents Salicylic acid, urea
D11AD Anti‑pruritic preparations Capsaicin, menthol
D11AE Other topical agents (e.g., sunscreens, astringents) Zinc oxide, aluminum chloride

The exact composition of sub‑groups may evolve as new agents are approved.


Clinical Use

Products classified under D11 are employed for a broad array of cutaneous conditions, including:

  • Bacterial skin infections – topical antibiotics (e.g., impetigo, minor wounds).
  • Disinfection and antisepsis – preparation for surgical sites or minor cuts.
  • Hyperkeratosis and callus removal – keratolytic agents in podiatry or dermatology.
  • Itch relief – topical antipruritics for eczema, insect bites, or allergic dermatitis.
  • Adjunctive skin care – barrier protectants, astringents, and sunscreen agents that do not fit other ATC categories.

Because the D11 group gathers “miscellaneous” dermatological products, it provides a flexible classification for agents that are either multifunctional or unique in their mechanism of action.


Examples of Medicines (selected)

Product (trade name) Active ingredient(s) ATC code
Bactroban Mupirocin 2 % (ointment) D11AA01
Fucidin Fusidic acid 2 % (cream) D11AA04
Savlon Chlorhexidine 0.5 % (solution) D11AB02
Polysporin Polymyxin B + Bacitracin (ointment) D11AA03
Salicylanilide Salicylanilide 5 % (cream) D11AC01
Zincox Zinc oxide 20 % (paste) D11AE01
Capzasin Capsaicin 0.025 % (gel) D11AD01

ATC codes are illustrative; commercial products may be listed under slightly different sub‑codes depending on formulation.


Regulatory and Data Sources

  • World Health Organization (WHO). Anatomical Therapeutic Chemical (ATC) Classification System. Updated annually; latest version available on WHO Collaborating Centre for Drug Statistics Methodology website.
  • European Medicines Agency (EMA). Product information sheets and SPCs (Summary of Product Characteristics) for dermatological preparations.
  • U.S. Food and Drug Administration (FDA). Orange Book and National Drug Code (NDC) listings for topical agents.

See Also

  • ATC classification system – overview of the global drug coding methodology.
  • Dermatologicals (ATC D) – the broader anatomical group containing D11.
  • Topical antibiotics – detailed classifications (e.g., D06A).
  • Keratinolytics – pharmacology of agents that soften keratin (e.g., salicylic acid).

References

  1. WHO Collaborating Centre for Drug Statistics Methodology. ATC/DDD Index 2023. https://www.whocc.no/atc_ddd_index/
  2. European Medicines Agency. Guideline on the classification of dermatological medicinal products. 2022.
  3. FDA. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. 2023.

This entry provides a concise yet comprehensive description of ATC code D11, suitable for reference in academic, clinical, and regulatory contexts.

Browse

More topics to explore